HomeCONGRESS

CONGRESS

View Category
Events

Structural Summit SBHCI 2023: Structural heart Intervention Frontier

The Latin American Society of Interventional Cardiology is inviting the medical community to take part of the...
solaci -
Learn More
Events

The EuroPCR 2023 is coming

EuroPCR 2023, one of the most important events in interventional cardiology, will be held in Paris, France,...
solaci -
Learn More
Other

ACC 2023 | COORDINATE-DIABETES

Approximately only 2.7% of all diabetic patients with ischemic heart disease in the United States receive optimal...
solaci -
Learn More
Other

ACC 2023 | A DUE-Study (Phase III)

In pulmonary hypertension (PHT), 10 mg macitentan plus 40 mg tadalafil is recommended as a safe combination therapy for...
solaci -
Learn More
Acute coronary syndromes

ACC 2023 | Ultrasensitive Troponin I Monitoring with a Transdermal Wrist Device

Over the years, early diagnosis of myocardial ischemia has ranged from 0-to-3-h protocols to abbreviated guidelines with...
solaci -
Learn More
Other

ACC 2023 | PULSE-AF

Catheter ablation is an effective treatment for patients with atrial fibrillation (AF) refractory to the standard medical...
solaci -
Learn More
Chronic Coronary Syndromes

ACC 2023 | Subanalysis of the REVIVED-BICS Study2

This study demonstrated that coronary angioplasty does not entail any benefit in chronic stable angina over optimal...
solaci -
Learn More
Chronic Ischemic cardiopathy

ACC 2023 | YELLOW III Study. Effect of Evolocumab on Coronary Plaque Characteristics in Stable Coronary Artery Disease

Dr. Kini presented the results of the YELLOW III Study where she analyzed the effect of evolocumab...
solaci -
Learn More